期刊文献+

视神经脊髓炎谱系疾病患者血清和脑脊液尿酸水平变化观察 被引量:2

Changes in levels of UA from serum and cerebrospinal fluid in NMOSD patients
下载PDF
导出
摘要 目的观察视神经脊髓炎谱系疾病(NMOSD)患者血清和脑脊液尿酸(UA)水平变化,并探讨其临床意义。方法纳入30例NMOSD患者(NMOSD组)、23例非炎症性神经系统疾病患者(NIND组)、26例健康对照者(HC组),采用尿酸酶法检测治疗前血清和脑脊液UA水平。比较各组血清、脑脊液UA水平及不同临床特征的NMOSD患者血清、脑脊液UA水平;采用Spearman相关性分析脑脊液UA与血清UA水平的相关性。结果NMOSD组血清UA水平低于NIND组和HC组(P均<0.05);NMOSD组脑脊液UA水平高于NIND组,但差异无统计学意义(P=0.153)。不同临床特征的NMOSD患者血清、脑脊液UA水平比较,P均>0.05。在NMOSD患者中,脑脊液UA水平与血清UA水平呈正相关(r=0.495,P=0.005)。结论NMOSD患者血清UA水平降低,脑脊液UA水平未见降低。血清、脑脊液UA水平与NMOSD患者临床病理特征无关。脑脊液UA与血清UA水平有正相关关系。 Objective To observe the changes in levels of uric acid(UA)from serum and cerebrospinal fluid in pa-tients with neuromyelitis optica spectrum disorders(NMOSD)and to investigate the clinical significance.Methods Thirty NMOSD patients(NMOSD group),23 non-inflammatory neurological disorders patients(NIND group),and 26 healthy controls(HC group)were included in this study.Uricase method was performed to detect cerebrospinal fluid and serum UA levels before the treatment.We compared the differences in the cerebrospinal fluid and serum UA levels be-tween these three groups,as well as between NMOSD patients with different clinical characteristics.Spearman correlation was used to analyze the correlation between cerebrospinal fluid UA and serum UA levels.Results The serum UA level in the NMOSD group was significantly lower than those in the NIND and HC groups(both P<0.05).The cerebrospinal flu-id UA level in the NMOSD group was higher than that in the NIND group,without a statistical significance(P=0.153).No statistically significant differences were found in the comparisons of serum and cerebrospinal fluid UA levels between NMOSD patients with different clinical characteristics(all P>0.05).There was a positive correlation between serum and cerebrospinal fluid UA levels in NMOSD patients(r=0.495,P=0.005).Conclusions In NMOSD patients,the cerebro-spinal fluid UA level did not decrease while the serum UA level is reduced.There are no correlations between clinical char-acteristics and the UA levels from serum and cerebrospinal fluid in NMOSD patients.There is a positive correlation be-tween cerebrospinal fluid and serum UA levels in NMOSD patients.
作者 李雪晶 常生辉 齐媛 杨丽 刘广宇 孙丽莎 LI Xuejing;CHANG Shenghui;QI Yuan;YANG Li;LIU Guangyu;SUN Lisha(Medical Laboratory,Tianjin Medical University General Hospital,Tianjin 300052,China;不详)
出处 《山东医药》 CAS 2021年第27期1-5,共5页 Shandong Medical Journal
基金 天津市卫生局科技基金项目(2014KZ117)。
关键词 尿酸 中枢神经系统自身免疫性疾病 视神经脊髓炎谱系疾病 uric acid autoimmune diseases of central nervous system neuromyelitis optica spectrum disorders
  • 相关文献

参考文献4

二级参考文献63

  • 1Weinshenker BG.Neuromyelitis optica is distinct from multiple sclerosis.Arch Neurol,2007,64:899-901.
  • 2van der Veen RC,Hinton DR,Incardonna F,et al.Extensive peroxynitrite activity during progressive stages of central nervous system inflammation.J Neuroimmunol,1997,77:1-7.
  • 3Rentzos M,Nikolaou C,Anagnostouli M,et al.Serum uric acid and multiple sclerosis.Clin Neurol Neurosurg,2006,108:527-531.
  • 4Wingerchuk DM,Lennon VA,Pittock SJ,et al.Revised diagnostic criteria for neuromyelitis optica.Neurology,2006,66:1485-1489.
  • 5Polman CH,Reingold SC,Edan G,et al.Diagnostic criteria for multiple sclerosis:2005 revisions to the "McDonald Criteria".Ann Neurol,2005,58:840-846.
  • 6Vladimirova O,O'Connor J,Cahill A,et al.Oxidative damage to DNA in plaques of MS brains.Mult Scler,1998,4:413-418.
  • 7Hooper DC,Bagasra O,Marini JC,et al.Prevention of experimental allergic encephalomyelitis by targeting nitric oxide and peroxynitrite:implications for the treatment of multiple sclerosis.Proc Natl Acad Sci U S A,1997,94:2528-2533.
  • 8Toncev G,Milicic B,Toncev S,et al.Serum uric acid levels in multiple sclerosis patients correlate with activity of disease and blood-brain barrier dysfunction.Eur J Neurol,2002,9:221-226.
  • 9Peng F,Zhang B,Zhong X,et al.Serum uric acid levels of patients with multiple sclerosis and other neurological diseases.Mult Scler,2008,14:188-196.
  • 10Constantinescu CS,Freitag P,Kappos L.Increase in serum levels of uric acid,an endogenous antioxidant,under treatment with glatiramer acetate for multiple sclerosis.Mult Scler,2000,6:378-381.

共引文献10

同被引文献21

引证文献2

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部